Genetics in Reproduction Flashcards

1
Q

reasons for referral to genetics

A
• FHx of genetic condition in relatives
• Diagnosis of genetic conditions – known/unknown
• Management of genetic conditions
• Genetic counselling
o Aiding decision making
o Increasing understanding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is non-invasive prenatal testing?

A

Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS) is a new genetic test that uses cell-free circulating fetal DNA in the maternal serum to screen for the more common fetal aneuploidies: trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome) and monosomy X (Turner syndrome).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do people need to know before undergoing a genetic test?

A
  • What a test is for/what’s the point in having it done?
  • How likely is it to be positive?
  • What happens if it is positive?
  • What if its negative?
  • What if false positive/false negative?
  • Implications for other family members of positive results
  • DNA stored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is amniocentesis?

A

Amniocentesis is a test you may be offered during pregnancy to check if your baby has a genetic or chromosomal condition, such as Down’s, Edwards’ or Patau’s syndrome.

It involves removing and testing a small sample of cells from the amniotic fluid – the fluid that surrounds the unborn baby in the womb (uterus).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is chorionic villus sampling?

A

Chorionic villus sampling (CVS) is a test you may be offered during pregnancy to check if your baby has a genetic or chromosomal condition, such as Down’s syndrome, Edwards’ syndrome or Patau’s syndrome.

It involves removing and testing a small sample of cells from the placenta (the organ linking the mother’s blood supply with her unborn baby’s).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is preimplantation genetic diagnosis?

A

The term preimplantation genetic screening (PGS) refers to the set of techniques for testing whether embryos (obtained through IVF/ICSI) have abnormal chromosomes’ number. In other words, it tests if embryo is aneuploid or not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

duchenne muscular dystrophy: inheritance

A

x linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

duchenne muscular dystrophy: screening

A

carrier testing
prenatal diagnosis
pre implanation diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

down syndrome: screening

A
• Maternal age
• Triple screening
• CUBS screening
• Selection for amniocentesis
• Free foetal DNA
o £500 at private clinics
o Coming to NHS
o Needs checked as risk of error, but negative predictive value high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

common recessive disorders that raise screening issues

A
CF
sickle cell disease
thalassaemia
ashkenazi jews
tay-sachs disease
CF W1282X
BRCA1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

carrier testing available by targetted testing in the UK

A

CF mutation analysis 80-90% sensitive UK (refer clinical genetics)
• Haemoglobinopathy MCV, Hb electrophoresis, sickledex (D/W haemoatoloy lab)
• Tay-Sachs enzyme activity (refer clinical genetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

types of pregnancy testing:

A

targeted

whole population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

discuss cystic fibrosis and genetic testin

A

1 in 2000 people are affected by CF. It is a result of defective cellular chloride transport.
Meconium ileus is a bowel obstruction that occurs when the meconium in your child’s intestine
is even thicker and stickier than normal meconium, creating a blockage in a part of the small
intestine called the ileum. Most infants with meconium ileus have a disease called cystic
fibrosis. Patients with CF suffer from recurrent lung infections. They often have pancreatic
insufficiency. Diagnosis is made on immunoreactive trypsin in first 6 weeks, sweat test and
genotyping. More than 1000 gene mutations cause disease. Some of these are particularly
common which enables genetic diagnosis, screening and prenatal diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is Tay-Sachs disease

A

Tay-Sachs is a progressive, genetic, lysosomal storage disease. Hexosaminidase A (hex-A)
deficiency results in the build-up of lipid GM(2) ganglioside especially in the nerve cells in the
brain. The baby usually develops normally until about 6 months when there is progressive
neurological deterioration. It is usually fatal by 3-5 years. 1 in 25 Ashkenazi Jews and 1 in 250
of the general population are carriers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is newborn screening done?

A

clinical exam
hearing
blood spot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why do we screen newborns?

A

It enables early detection of pre-symptomatic babies. It enables early treatment to improve health. To reduce anxiety caused by uncertainty over symptoms before clinical diagnosis is made.

17
Q

what do we screen newborns for?

A
  1. PKU – phenylketonuria
  2. CHT – congenital hypothyroidism
  3. SCD
  4. CF
  5. MCADD – medium chain acyl-CoA dehydrogenase deficiency
  6. Homocysteinuria
  7. Isovaleric acidaemia
  8. Maple syrup urine disease
  9. Glutaric aciduria type 1
18
Q

discuss PKU ad screening

A

PKU affects approximately 1 in 10,000 babies in the UK i.e. around 80 born each year. It is a
recessive conditions that is identified by a biochemical screen. Carriers are not identified.
Babies with the condition are unable to break down phenylalanine (an amino acid in protein).
Untreated babies develop serious, irreversible, mental disability. Early treatment with a strictly
controlled diet prevents disability. Treatment should start by 21 days of age.

19
Q

discuss congenital hypothyroidism and screening

A

CHT affects 1 in 4,000 babies in the UK. 1 in 10 cases are inherited. Carriers are not identified.
It results in not enough thyroxine being produced. Untreated babies have serious, permanent,
physical and mental disability. Early treatment with thyroxine tablets prevents disability.
Treatment should start by 21 days.

20
Q

discuss medium chain acyl-CoA dehydrogenase deficiency and screening

A

In the UK this condition affects 1 in 10,000-20,000 babies. It is a recessive inherited condition
and once again carries are not identified. Babies with MCADD cannot easily break down fat
to make energy for the body. Serious life-threatening symptoms can occur quickly in babies
not feeding well or unwell. Mean age at first presentation is 14 months. There is a 25%
mortality rate with MCADD. Treatment to prevent a metabolic crisis: avoid fasting and monitor
frequency of meals. Emergency regimen: glucose polymer (maxijul) and IV dextrose.